Jul 3, 2022 | Cosmetics, Dietary Supplements, Drugs, EAS in Action, EAS in the News Cosmetics, EAS in the News Dietary Supplements, EAS in the News Drugs, EAS in the News Medical Device, EASeNews, Medical Devices
EAS Consultant, Tamika Cathey, is featured in Tablets and Capsules magazine with an article on establishing an effective environmental monitoring program. Contamination is costly, with recalls and fines for problematic products in the hundreds of millions. EAS offers...
Apr 25, 2022 | Dietary Supplements, Drugs, EAS in Action, EAS in the News Dietary Supplements, EAS in the News Drugs
EAS Independent Consultant and expert in packaging solutions for FDA industries, Jim Goldman, wrote an article on quality considerations and mitigations of supplier and customer challenges that was published in Tablets and Capsules. EAS experts such as Jim help...
Jul 19, 2021 | Dietary Supplements, EAS in the News Dietary Supplements
The pandemic has resulted in an increase in the number of misbranded dietary supplements. As a result, FDA is using updated, alternative, and remote enforcement tools to ensure compliance. Tara Couch, Senior Director for dietary supplement and tobacco services covers...
Aug 1, 2020 | Dietary Supplements, EAS in Action, EAS in the News Dietary Supplements
James Hoadley, Ph.D. wrote an article on ensuring use of legal dietary supplement ingredients for Natural Product Insider. Regulators have a fine focus on dietary supplement products that are mislabeled or misbranded, and brands must be careful when it comes to...
Aug 1, 2020 | Dietary Supplements, EAS in Action, EAS in the News Dietary Supplements
Senior Director for Dietary Supplements and Tobacco Services, Tara Lin Couch, Ph.D. authored an article on How to Perform an OOS Investigation for Tablets and Capsules magazine. EAS is a recognized industry leader for regulatory services to the dietary supplement...
Jun 1, 2020 | Dietary Supplements, EAS in Action, EAS in the News Dietary Supplements
For a number of years, many dietary supplements have been produced by contract manufacturers. As manufacturing processes become more sophisticated (e.g., complex probiotics) and FDA regulatory requirements continue to expand, it becomes more cost-effective to use the...
